Geneos therapeutics announces clinical updates on personalized cancer vaccine program

Plymouth meeting, pa., june 3, 2021 /prnewswire/ -- geneos therapeutics, a clinical stage company focused on the development of tumor neoantigen targeted personalized immunotherapies for cancer, announced today positive preliminary results of its ongoing first-in-human trial.
INO Ratings Summary
INO Quant Ranking